je.st
news
Tag: drug
Pfizer, Allergan in deal talks to create drug giant
2015-10-30 12:30:01| Biotech - Topix.net
Pfizer and Botox maker Allergan are discussing a potential deal that could be the biggest of 2015, a year marked by a rapid-fire pace of megadeals, particularly in health care. A merger could enable Viagra maker Pfizer, the world's second-biggest drugmaker by revenue, to surpass Switzerland's Novartis AG and regain the industry's top spot.
Signatures to be filed for California drug price referendum
2015-10-29 21:02:10| Biotech - Topix.net
Backers of a referendum aimed at reducing the cost of prescription drugs in California said Wednesday that they had gathered more than enough signatures to place their measure on the November, 2016, ballot in the most populous U.S. state. The measure by the AIDS Healthcare Foundation would require the state to pay no more for prescription medications than does the federal Veterans Administration, which negotiates aggressively with drug companies.
Tags: price
california
filed
drug
Merck And Pfizer Showing Significant Upside Potential From Increased Drug Sales Outlook
2015-10-29 16:49:19| Biotech - Topix.net
Merck and Pfizer are leading investment options in the pharmaceutical healthcare sector given the lower risk and higher return they offer investors over smaller capitalization stocks. Third quarter earnings for Merck and Pfizer showed significant potential for value gains as both drug manufacturers beat earnings expectations and increased their guidance for 2015 as a result of improving dynamics in the healthcare sector.
Tags: sales
showing
significant
potential
FDA approves drug that uses herpes virus to fight cancer
2015-10-28 17:54:23| Biotech - Topix.net
The Food and Drug Administration approved the injectable drug from Amgen Inc. for patients with hard-to-treat melanoma, the deadliest form of skin cancer that is expected to be diagnosed in 74,000 U.S. patients this year. For now, the drug is only approved for melanoma tumors that cannot be removed surgically.
Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study
2015-10-28 08:39:05| Biotech - Topix.net
Amgen Inc and Cytokinetics Inc said on Tuesday their experimental drug for chronic heart failure showed significant improvement in cardiac function in the second part of a mid-stage study. The 448 patients in the trial were given an oral formulation of the drug omecamtiv mecarbil for 20 weeks and observed for 24 weeks, the companies said in a joint statement.
Tags: study
heart
drug
failure
Sites : [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] next »